Subscribe Now
Not getting email updates?

A Pharmacy Perspective on the Rx Pipeline

News on development of the first oral GLP-1 Receptor Agonist for type 2 diabetes and more

News on development of the first oral GLP-1 Receptor Agonist for type 2 diabetes and more

EnvisionPharmacies demonstrates excellence with new specialty key performance indicator reporting. With ...

News on an intranasal medication for managing hypoglycemia in type 1 diabetics and more ...

EnvisionPharmacies continuously monitors the drug pipeline, evaluating changes to treatment options in order to ...

EnvisionPharmacies continuously monitors the drug pipeline, evaluating changes to treatment options in order to ...

EnvisionPharmacies continuously monitors the drug pipeline, evaluating changes to treatment options in order to ...